Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,464 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · derivative · entry 15 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 5,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. F7 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F7 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F8 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · derivative · entry 14 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. F7 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F7 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F8 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · derivative · entry 13 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. F7 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F7 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F8 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · derivative · entry 12 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. F7 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F7 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F8 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · derivative · entry 11 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. F7 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F7 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F8 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Tax withholdingOrdinary Shares | 1,499 | $8.35 | $12,516.65 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 10 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,266 F6 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,499 ordinary shares on net exercise of option to purchase 5,464 ordinary shares. The Company withheld 3,965 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.35, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionOrdinary Shares | 5,464 | $5.93 | $32,401.52 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 9 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Tax withholdingOrdinary Shares | 1,783 | $8.36 | $14,905.88 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 8 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,266 F5 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,783 ordinary shares on net exercise of option to purchase 6,500 ordinary shares. The Company withheld 4,717 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionOrdinary Shares | 6,500 | $5.93 | $38,545.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 7 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Tax withholdingOrdinary Shares | 1,371 | $8.36 | $11,461.56 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 6 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,266 F4 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionOrdinary Shares | 5,000 | $5.93 | $29,650.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 5 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Tax withholdingOrdinary Shares | 1,371 | $8.36 | $11,461.56 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 4 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,266 F3 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionOrdinary Shares | 5,000 | $5.93 | $29,650.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 3 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Tax withholdingOrdinary Shares | 1,371 | $8.36 | $11,461.56 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 2 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,266 F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:40 UTC |
Brenner YaelVP Quality
|
Exercise / conversionOrdinary Shares | 5,000 | $5.93 | $29,650.00 |
DisclosureSEC source: 0001213900-26-100845 · ownership.xml · nonDerivative · entry 1 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:37 UTC |
Livneh NirVP, General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001213900-26-100842 · ownership.xml · derivative · entry 3 Livneh Nir · CIK 0002067543 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:37 UTC |
Livneh NirVP, General Counsel
|
Tax withholdingOrdinary Shares | 3,459 | $8.35 | $28,882.65 |
DisclosureSEC source: 0001213900-26-100842 · ownership.xml · nonDerivative · entry 2 Livneh Nir · CIK 0002067543 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 3,459 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 6,541 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.35, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:37 UTC |
Livneh NirVP, General Counsel
|
Exercise / conversionOrdinary Shares | 10,000 | $5.37 | $53,700.00 |
DisclosureSEC source: 0001213900-26-100842 · ownership.xml · nonDerivative · entry 1 Livneh Nir · CIK 0002067543 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 15:33 UTC |
Tsur DavidDirector
|
SaleOrdinary Shares | 22,827 | $8.18 | $186,724.86 |
DisclosureSEC source: 0001213900-26-100839 · ownership.xml · nonDerivative · entry 1 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407,929 F1 · price: The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. Read SEC document |
| September 09, 2026 Filed Sep 11, 2026 15:29 UTC |
Tsur DavidDirector
|
SaleOrdinary Shares | 175 | $8.26 | $1,445.50 |
DisclosureSEC source: 0001213900-26-099060 · ownership.xml · nonDerivative · entry 3 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,756 F3 · price: The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 9, 2026. Read SEC document |
| September 08, 2026 Filed Sep 11, 2026 15:29 UTC |
Tsur DavidDirector
|
SaleOrdinary Shares | 162,760 | $8.26 | $1,344,397.60 |
DisclosureSEC source: 0001213900-26-099060 · ownership.xml · nonDerivative · entry 2 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,931 F2 · price: The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 8, 2026. Read SEC document |
| September 07, 2026 Filed Sep 11, 2026 15:29 UTC |
Tsur DavidDirector
|
SaleOrdinary Shares | 14,238 | $8.28 | $117,890.64 |
DisclosureSEC source: 0001213900-26-099060 · ownership.xml · nonDerivative · entry 1 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 593,691 F1 · price: The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 7, 2026. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Brenner YaelVP Quality
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,036 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001213900-26-097830 · ownership.xml · derivative · entry 3 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 3,036 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. F3 · derivative.exercise_price: This option was previously reported as covering 3,036 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. F4 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F4 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. F5 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Brenner YaelVP Quality
|
Tax withholdingOrdinary Shares | 865 | $8.37 | $7,240.05 |
DisclosureSEC source: 0001213900-26-097830 · ownership.xml · nonDerivative · entry 2 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,266 F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 865 ordinary shares on net exercise of option to purchase 3,036 ordinary shares. The Company withheld 2,171 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.37, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Brenner YaelVP Quality
|
Exercise / conversionOrdinary Shares | 3,036 | $5.94 | $18,033.84 |
DisclosureSEC source: 0001213900-26-097830 · ownership.xml · nonDerivative · entry 1 Brenner Yael · CIK 0002064606 · VP Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. F3 · price: This option was previously reported as covering 3,036 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Tsur DavidDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001213900-26-097829 · ownership.xml · derivative · entry 6 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 22,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. F6 · derivative.exercise_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. F6 · derivative.expiration_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. F7 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Tsur DavidDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $7.36 | $0.00 |
DisclosureSEC source: 0001213900-26-097829 · ownership.xml · derivative · entry 5 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 0 Underlying: Ordinary Shares · 26,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. F6 · derivative.exercise_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. F6 · derivative.expiration_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. F7 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Tsur DavidDirector
|
Tax withholdingOrdinary Shares | 6,406 | $8.26 | $52,913.56 |
DisclosureSEC source: 0001213900-26-097829 · ownership.xml · nonDerivative · entry 4 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 607,929 F3 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 6,406 ordinary shares on net exercise of option to purchase 22,500 ordinary shares. The Company withheld 16,094 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.26, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Tsur DavidDirector
|
Exercise / conversionOrdinary Shares | 22,500 | $5.94 | $133,650.00 |
DisclosureSEC source: 0001213900-26-097829 · ownership.xml · nonDerivative · entry 3 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. F5 · price: This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Tsur DavidDirector
|
Tax withholdingOrdinary Shares | 2,760 | $8.30 | $22,908.00 |
DisclosureSEC source: 0001213900-26-097829 · ownership.xml · nonDerivative · entry 2 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 607,929 F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 2,760 ordinary shares on net exercise of option to purchase 26,500 ordinary shares. The Company withheld 23,740 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.30, pursuant to the terms of the Company's 2011 Share Award Plan. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. Read SEC document |
| September 02, 2026 Filed Sep 8, 2026 11:00 UTC |
Tsur DavidDirector
|
Exercise / conversionOrdinary Shares | 26,500 | $7.36 | $195,040.00 |
DisclosureSEC source: 0001213900-26-097829 · ownership.xml · nonDerivative · entry 1 Tsur David · CIK 0002069828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. F4 · price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:27 UTC |
Asher-Topilsky LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001213900-26-104374 · ownership.xml · derivative · entry 3 Asher-Topilsky Lilach · CIK 0002128355 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F6 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.42. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:27 UTC |
Asher-Topilsky LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001213900-26-104374 · ownership.xml · derivative · entry 2 Asher-Topilsky Lilach · CIK 0002128355 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.05. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:27 UTC |
Asher-Topilsky LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $7.29 | $0.00 |
DisclosureSEC source: 0001213900-26-104374 · ownership.xml · derivative · entry 1 Asher-Topilsky Lilach · CIK 0002128355 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 26,500 Underlying: Ordinary Shares · 26,500 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.45. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:13 UTC |
DAVIDI ISHAYDirector · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001213900-26-104355 · ownership.xml · derivative · entry 3 DAVIDI ISHAY · CIK 0001426753 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F6 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.42. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:13 UTC |
DAVIDI ISHAYDirector · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001213900-26-104355 · ownership.xml · derivative · entry 2 DAVIDI ISHAY · CIK 0001426753 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.05. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:13 UTC |
DAVIDI ISHAYDirector · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $7.29 | $0.00 |
DisclosureSEC source: 0001213900-26-104355 · ownership.xml · derivative · entry 1 DAVIDI ISHAY · CIK 0001426753 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 26,500 Underlying: Ordinary Shares · 26,500 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.45. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:08 UTC |
Botzer UriDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001213900-26-104353 · ownership.xml · derivative · entry 2 Botzer Uri · CIK 0002128353 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.42. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 29, 2026 13:08 UTC |
Botzer UriDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001213900-26-104353 · ownership.xml · derivative · entry 1 Botzer Uri · CIK 0002128353 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $5.39. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 25, 2026 10:23 UTC |
London AmirChief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001213900-26-103207 · ownership.xml · derivative · entry 2 London Amir · CIK 0002067536 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 400,000 Underlying: Ordinary Shares · 400,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 400,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 25, 2026 10:23 UTC |
London AmirChief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $5.99 | $0.00 |
DisclosureSEC source: 0001213900-26-103207 · ownership.xml · derivative · entry 1 London Amir · CIK 0002067536 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 400,000 Underlying: Ordinary Shares · 400,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 400,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 19:28 UTC |
Gorelik BorisVP, BD and Strategic Programs
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001213900-26-103014 · ownership.xml · derivative · entry 1 Gorelik Boris · CIK 0002069784 · VP, BD and Strategic Programs 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 15,000 ordinary shares at an exercise price of $9.57. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 19:22 UTC |
Payorski LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0001213900-26-103011 · ownership.xml · derivative · entry 2 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 19:22 UTC |
Payorski LilachDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.99 | $0.00 |
DisclosureSEC source: 0001213900-26-103011 · ownership.xml · derivative · entry 1 Payorski Lilach · CIK 0002007989 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 19:20 UTC |
Reshef LironVP Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001213900-26-103010 · ownership.xml · derivative · entry 2 Reshef Liron · CIK 0002067542 · VP Human Resources 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 19:20 UTC |
Reshef LironVP Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001213900-26-103010 · ownership.xml · derivative · entry 1 Reshef Liron · CIK 0002067542 · VP Human Resources 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 40,000 ordinary shares at an exercise price of $5.29. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 11:00 UTC |
Goldwasser KarnitDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0001213900-26-102825 · ownership.xml · derivative · entry 3 Goldwasser Karnit · CIK 0002071721 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F6 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 11:00 UTC |
Goldwasser KarnitDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.99 | $0.00 |
DisclosureSEC source: 0001213900-26-102825 · ownership.xml · derivative · entry 2 Goldwasser Karnit · CIK 0002071721 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 11:00 UTC |
Goldwasser KarnitDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001213900-26-102825 · ownership.xml · derivative · entry 1 Goldwasser Karnit · CIK 0002071721 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 26,500 Underlying: Ordinary Shares · 26,500 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 24, 2026 11:00 UTC |
Beladev ShavitVP Plasma Operations
|
GrantEmployee Stock Option(right to buy) · Derivative | 60,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001213900-26-102824 · ownership.xml · derivative · entry 2 Beladev Shavit · CIK 0002068363 · VP Plasma Operations 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.